Literature DB >> 15480518

[Management of coagulation after multiple trauma].

D Fries1, T Haas, V Salchner, K Lindner, P Innerhofer.   

Abstract

Hemorrhage after traumatic injury results in coagulopathy which only worsens the situation. This coagulopathy is caused by depletion and dilution of clotting factors and platelets, increased fibrinolytic activity, hypothermia, metabolic changes and anemia. The effect of synthetic colloids used for compensating the blood loss, further aggravates the situation through their specific action on the hemostatic system. Bedside coagulation monitoring permits relevant impairment of the coagulation system to be detected very early and the efficacy of the hemostatic therapy to be controlled directly. Administration of fresh frozen plasma (FFP), platelet concentrates and antifibrinolytic agents is essential for restoring the impaired coagulation system in trauma patients. Clotting factor concentrates should be administered if coagulopathy is based on diagnosed depletion of clotting factors, if FFP is not available and if transfusion of FFP is insufficient to treat the coagulopathy. Recombined FVIIa is frequently employed during severe bleeding which could not be treated by conventional methods but the results of on-going clinical trials are not yet available.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15480518     DOI: 10.1007/s00101-004-0760-7

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  34 in total

1.  Coagulation effects of a recently developed hydroxyethyl starch (HES 130/0.4) compared to hydroxyethyl starches with higher molecular weight.

Authors:  E K Entholzner; L L Mielke; A N Calatzis; J Feyh; R Hipp; S R Hargasser
Journal:  Acta Anaesthesiol Scand       Date:  2000-10       Impact factor: 2.105

2.  Early coagulopathy predicts mortality in trauma.

Authors:  Jana B A MacLeod; Mauricio Lynn; Mark G McKenney; Stephen M Cohn; Mary Murtha
Journal:  J Trauma       Date:  2003-07

3.  Practice Guidelines for blood component therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy.

Authors: 
Journal:  Anesthesiology       Date:  1996-03       Impact factor: 7.892

4.  Thromboembolic complications associated with the use of prothrombin complex and factor IX concentrates.

Authors:  M Köhler; P Hellstern; E Lechler; P Uberfuhr; G Müller-Berghaus
Journal:  Thromb Haemost       Date:  1998-09       Impact factor: 5.249

5.  Predicting life-threatening coagulopathy in the massively transfused trauma patient: hypothermia and acidoses revisited.

Authors:  N Cosgriff; E E Moore; A Sauaia; M Kenny-Moynihan; J M Burch; B Galloway
Journal:  J Trauma       Date:  1997-05

Review 6.  Trauma critical care.

Authors:  L M Gentilello; D J Pierson
Journal:  Am J Respir Crit Care Med       Date:  2001-03       Impact factor: 21.405

Review 7.  Tranexamic acid: a review of its use in surgery and other indications.

Authors:  C J Dunn; K L Goa
Journal:  Drugs       Date:  1999-06       Impact factor: 9.546

8.  Recombinant activated factor VII for adjunctive hemorrhage control in trauma.

Authors:  U Martinowitz; G Kenet; E Segal; J Luboshitz; A Lubetsky; J Ingerslev; M Lynn
Journal:  J Trauma       Date:  2001-09

9.  Hemostasis and hemodilution: a quantitative mathematical guide for clinical practice.

Authors:  Kai Singbartl; Petra Innerhofer; Jens Radvan; Birgit Westphalen; Dietmar Fries; Raimund Stögbauer; Hugo Van Aken
Journal:  Anesth Analg       Date:  2003-04       Impact factor: 5.108

10.  Epidemiology of trauma deaths: a reassessment.

Authors:  A Sauaia; F A Moore; E E Moore; K S Moser; R Brennan; R A Read; P T Pons
Journal:  J Trauma       Date:  1995-02
View more
  7 in total

Review 1.  [Fresh plasma and concentrates of clotting factors for therapy of perioperative coagulopathy: what is known?].

Authors:  B Heindl; M Spannagl
Journal:  Anaesthesist       Date:  2006-09       Impact factor: 1.041

2.  [Therapy of perioperative coagulopathy].

Authors:  M Schöler; A Weiler-Lorentz; T Frietsch
Journal:  Anaesthesist       Date:  2008-04       Impact factor: 1.041

3.  [Perioperative hemostasis management].

Authors:  A Tiede
Journal:  Chirurg       Date:  2007-01       Impact factor: 0.955

Review 4.  [Perioperative management of Jehovah's Witness patients. Special consideration of religiously motivated refusal of allogeneic blood transfusion].

Authors:  O Habler; B Voss
Journal:  Anaesthesist       Date:  2010-04       Impact factor: 1.041

Review 5.  Coagulation management in multiple trauma: a systematic review.

Authors:  Heiko Lier; Bernd W Böttiger; Jochen Hinkelbein; Henning Krep; Michael Bernhard
Journal:  Intensive Care Med       Date:  2011-02-12       Impact factor: 17.440

Review 6.  [Prerequisites of a functional haemostasis. What must be considered at the scene of an accident, in the emergency room and during an operation?].

Authors:  H Lier; S Kampe; S Schröder
Journal:  Anaesthesist       Date:  2007-03       Impact factor: 1.041

Review 7.  [Coagulation management in the treatment of multiple trauma].

Authors:  H Lier; H Krep; H Schöchl
Journal:  Anaesthesist       Date:  2009-10       Impact factor: 1.041

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.